Compare Amphastar Pharmaceuticals Inc (AMPH) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Wix.Com Ltd — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while Wix.Com Ltd trades at $52.2 (market cap $2.10B). The key difference: Wix.Com Ltd is far larger — about 2.5× Amphastar Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMPH | WIX | |
|---|---|---|
Market Cap | $826.08M | $2.10B |
Sector | Health | Technology |
52-Week High | $30.81 | $184.24 |
52-Week Low | $16.87 | $40.43 |
Enterprise Value | $1.22B | $1.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Wix trades at $50.14, up 1.83% today, with a bearish technical signal despite recent earnings beats in Q3 and Q4 2025. Revenue grew to $1.99B in 2025, but net income margin remains negative at -1.97%. Recent news includes partnerships with Elavon and Microsoft, but multiple law firms are investigating potential securities fraud following a 27% stock drop in May 2026.
Analyst consensus is bullish with a $83.13 price target, but risks include ongoing fraud investigations, volatile cash flows, and negative shareholder equity. The stock faces headwinds from competitive pressures and execution risks despite strong revenue growth and institutional support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
